申请人:BAYER PHARMA AKTIENGESELLSCHAFT
公开号:US20150368260A1
公开(公告)日:2015-12-24
The present invention relates to isothiazoles of general formula (I) which inhibit the mitotic checkpoint: in which A, R1 and R2 are as defined in the claims, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neoplasms, as a sole agent or in combination with other active ingredients.
本发明涉及通式(I)的异噻唑类化合物,其抑制有丝分裂检查点:其中A,R1和R2如权利要求书所定义的那样,以及制备该化合物的方法,用于制备该化合物的中间体化合物,包括该化合物的药物组合物和组合物,以及使用该化合物制造用于治疗或预防疾病的药物组合物,特别是肿瘤,作为唯一的制剂或与其他活性成分联合使用。